Sen. Dianne Feinstein reduced biotech exposure worth up to $6M shortly before pandemic volatility hit the sector. As a member of the Senate Health Committee, her risk management timing demonstrated deep sector expertise.
🚩
Sen. Dianne Feinstein reduced biotech exposure worth up to $6M shortly before pandemic volatility hit the sector. As a member of the Senate Health Committee, her risk management timing demonstrated deep sector expertise.